$VVX

V2X, Inc.

No enriched coverage for $VVX in the last 7 days.

No SEC Form 4 filings for $VVX in the last 30 days.

See all $VVX insider activity →
Med

Should Carriage Equipment Order Require Action From V2X (VVX) Investors?

V2X Inc. secured a $46M order for Long Range Standoff (LRSO) carriage equipment for the U.S. Air Force, supporting its defense modernization programs. The order may bolster backlog but doesn't fully mitigate booking risks. Analysts project $5.6B revenue and $231.4M earnings by 2029, with potential upside. V2X's focus on long-range strike and counter-UAS systems presents opportunities and execution risks.

VVX Looks 18.1% Overvalued on GF Value™

V2X Inc. (NYSE: VVX) secured a $46M contract for the U.S. Air Force's LRSO cruise missile program. GF Value™ suggests VVX is 18.1% overvalued, trading at $72.96 vs. an estimated intrinsic value of $61.78. The company has a GF Score™ of 69/100, with strong profitability and growth but weak momentum. Insiders have sold $487.9M in shares over the past year, with no purchases.

V2X wins position on $46M Air Force missile contract

V2X Inc. (NYSE:VVX) secured a $46M contract for the U.S. Air Force's Long Range Standoff cruise missile program, supporting B-52 Stratofortress integration. The contract is part of the LRSO program, replacing the current Air-Launched Cruise Missile. V2X provides engineering and manufacturing services for defense and national security.

VVX sentiment & insider activity

Recent VVX coverage spans financial news, market movers and corporate actions.

What's driving VVX

AlphAI scores every news story that mentions VVX with an AI model for sentiment and relevance, and aggregates insider trades from V2X, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $VVX

Score
$VVXMed

Should Carriage Equipment Order Require Action From V2X (VVX) Investors?

V2X Inc. secured a $46M order for Long Range Standoff (LRSO) carriage equipment for the U.S. Air Force, supporting its defense modernization programs. The order may bolster backlog but doesn't fully mitigate booking risks. Analysts project $5.6B revenue and $231.4M earnings by 2029, with potential upside. V2X's focus on long-range strike and counter-UAS systems presents opportunities and execution risks.

$VVXMed

VVX Looks 18.1% Overvalued on GF Value™

V2X Inc. (NYSE: VVX) secured a $46M contract for the U.S. Air Force's LRSO cruise missile program. GF Value™ suggests VVX is 18.1% overvalued, trading at $72.96 vs. an estimated intrinsic value of $61.78. The company has a GF Score™ of 69/100, with strong profitability and growth but weak momentum. Insiders have sold $487.9M in shares over the past year, with no purchases.

$VVXMed

V2X wins position on $46M Air Force missile contract

V2X Inc. (NYSE:VVX) secured a $46M contract for the U.S. Air Force's Long Range Standoff cruise missile program, supporting B-52 Stratofortress integration. The contract is part of the LRSO program, replacing the current Air-Launched Cruise Missile. V2X provides engineering and manufacturing services for defense and national security.

$VVXHighAI 9/10

V2X (VVX) Lands A Long Runway With Its Latest Air Force Deal

V2X Inc. (VVX) secured a $500M contract with the US Air Force for C-12 Huron fleet services through 2031. The company reported Q2 revenue of $1.26B, up 17% YoY, and adjusted EPS of $1.64, up 23% YoY. Management raised its 2026 outlook and reduced net debt to $876.1M. The contract is a firm fixed price, transferring cost risk to V2X.

$VVXLow

V2X (VVX) Wins Fresh Defense Contracts, Is The Stock Still Undervalued?

V2X (VVX) secured new U.S. defense contracts, including deals with the Marine Corps, Navy, and Air Force. The stock has risen 48.76% year-to-date and 63.83% over three years. Analysts debate whether the stock is undervalued, with a fair value estimate of $89.09 compared to the current price of $82.65. The company's financial flexibility and potential for accelerated earnings growth are highlighted, but risks include delays in winning new contracts.

Related tickers